The nucleic acid extraction instruments and reagents market has seen considerable growth due to a variety of factors.
•There has been a robust growth in the market size of nucleic acid extraction instruments and reagents in the past few years. The market value is anticipated to rise from $4.56 billion in 2024 to $5.01 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.9%.
The growth during the historic phase could be linked to advancements in genomic research, expansion in clinical diagnostics, the introduction of next-generation sequencing, growing occurrence of genetic disorders, and a worldwide emphasis on research into infectious diseases.
The nucleic acid extraction instruments and reagents market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for nucleic acid extraction instruments and reagents is forecasted for a significant increase in the upcoming years. It is predicted that it will reach a value of $7.84 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%.
This projected growth over the forecast period can be linked to the swift expansion in personalized medicine, developments in point-of-care testing, an intensified focus on rare illnesses, and advancements in cancer studies. Furthermore, upcoming trends for the forecast period encompass applications in the field of agricultural biotechnology, technological breakthroughs in automation, the flourishing of biotechnology, environmental DNA (EDNA) examination, and the application of blockchain for genomic data protection.
The rise in chronic diseases is set to accelerate the expansion of the nucleic acid extraction instruments and reagents market. Chronic diseases, long-lasting ailments that often develop slowly over time, necessitate the use of nucleic acid extraction instruments and reagents, especially in molecular diagnostics and research. These instruments and reagents are critical in the research, diagnosis, monitoring, and treatment of chronic illnesses, enabling genetic testing, biomarker analysis, research, pharmacogenomic testing, and disease tracking, all contributing to improved comprehension and management of chronic diseases. For instance, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that in September 2023, of the 41 million deaths globally, 74% were due to non-communicable diseases or chronic diseases. There were 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the rise in chronic diseases is propelling the growth of the nucleic acid extraction instruments and reagents market.
The nucleic acid extraction instruments and reagents market covered in this report is segmented –
1) By Type: Instruments, Spin Columns, Beads Or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits And Reagents And Consumables, Other Types
2) By Extraction Type: DNA Extraction, DNA Or RNA Extraction, RNA Extraction
3) By Method: Solution-Based Methods, Solid-Phase-Based Methods
4) By End User: Academic Research Institutes, Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Industry, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) By Instruments: Manual Extraction Instruments, Automated Extraction Instruments, Specialized Nucleic Acid Extractors
2) By Spin Columns: Standard, High-Throughput, Specialized
3) By Beads Or Magnetic Beads: Silica-Based Beads, Magnetic Beads For DNA Or RNA Extraction, Functionalized Beads For Nucleic Acid Binding
4) By Automated Nucleic Acid Extraction Systems: Fully Automated Systems, Semi-Automated Systems
5) By Extraction Kits And Reagents And Consumables: DNA Extraction Kits, RNA Extraction Kits, Reagents For Nucleic Acid Purification, Consumables
6) By Other Types: Specialized Extraction Methods, Hybrid Methods
Key players in the nucleic acid extraction instruments and reagents market are concentrating their efforts on designing inventive solutions such as nucleic acid extraction systems. These systems are crafted to isolate and purify nucleic acids, including DNA and RNA, from a variety of biological samples like blood, tissue, cells, and other body fluids; signifying their priority is innovation and catering to market-specific needs. For example, in January 2024, LGC Biosearch Technologies, a biotechnology firm based in the UK, introduced a novel nucleic acid extraction technique named sbeadex Lightning. This new method transforms DNA purification by facilitating high-purity extraction from plant and animal matter in a remarkably quick 5-minute timeframe. By condensing the traditional five-step procedure into a simpler three-step process of binding, washing, and eluting, it saves up to 40 minutes per sample and potentially increases the throughput by a factor of ten. The DNA extracted by this process usually exhibits high purity, with 260/280 ratios between 1.7 and 2, making it an ideal choice for PCR and NGS applications.
Major companies operating in the nucleic acid extraction instruments and reagents market include:
• Thermo Fisher Scientific Inc.
• F Hoffmann-La Roche Ltd.
• Merck Group
• Corning Incorporated
• Agilent Technologies Inc.
• PerkinElmer
• Illumina Inc.
• Beckman Coulter
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Eppendorf AG
• LGC Biosearch Technologies
• Promega Corporation
• RBC Bioscience Corp.
• Takara Bio Inc.
• Meridian Bioscience
• Bioneer Corporation
• Macherey-Nagel
• New England Biolabs
• Miltenyi Biotec
• Omega Bio-tek
• BioVision Inc.
• Norgen Biotek Corp.
• Biosan Laboratories Inc.
• G-Biosciences
• ADS Biotec Inc.
• BioChain Institute Inc.
• Lucigen Corporation.
North America was the largest region in the nucleic acid extraction instruments and reagents market in 2024. The regions covered in the nucleic acid extraction instruments and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa